MetLife Small Company Equity Inst (MSVIX)

Fund Assets	7.71M
Expense Ratio	0.99%
Min. Investment	$100,000
Turnover	90.00%
Dividend (ttm)	0.01
Dividend Yield	0.20%
Dividend Growth	-60.07%
Payout Frequency	n/a
Ex-Dividend Date	Dec 30, 2025

Previous Close	5.71
YTD Return	13.75%
1-Year Return	15.66%
5-Year Return	60.35%
52-Week Low	4.67
52-Week High	13.86
Beta (5Y)	n/a
Holdings	78
Inception Date	Dec 19, 2018

About MSVIX

MetLife Small Company Equity Fund Institutional Shares is a mutual fund focused on delivering long-term capital appreciation through investments in U.S. small-cap equities. The fund primarily targets companies with smaller market capitalizations, aiming to harness their growth potential while seeking to maintain less volatility than the broader small company market. Its diversified portfolio typically includes equities across a variety of industries, allowing investors to gain exposure to multiple sectors within the small-cap universe. The fund's management employs a disciplined investment process, which has earned recognition for its soundness and the strength of the team behind it. This fund is benchmarked against the Russell 2000 Index, positioning it as a relevant vehicle for institutions or investors seeking targeted access to small-sized U.S. companies as part of a broader asset allocation strategy. Its institutional share class is designed to meet the needs of larger investors, such as retirement plans or endowments, looking for professional management in the small-cap segment.

• Fund Family: MetLife Investment Management
• Category: Small Blend
• Performance Rating: Average
• Risk Rating: Below Average
• Stock Exchange: NASDAQ
• Ticker Symbol: MSVIX
• Share Class: Institutional Shares
• Index: Russell 2000 TR

Performance

MSVIX had a total return of 15.66% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.41%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
MSVVX	Investor Shares	1.24%

Top 10 Holdings

19.70% of assets

Name	Symbol	Weight
Cash & Cash Equivalents	n/a	3.66%
Halozyme Therapeutics, Inc.	HALO	1.99%
Kontoor Brands, Inc.	KTB	1.99%
State Street SPDR S&P Biotech ETF	XBI	1.87%
Advanced Energy Industries, Inc.	AEIS	1.85%
Praxis Precision Medicines, Inc.	PRAX	1.74%
iShares Russell 2000 ETF	IWM	1.72%
Zions Bancorporation, National Association	ZION	1.65%
Gates Industrial Corporation Ltd.	GTES	1.64%
StandardAero, Inc.	SARO	1.60%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 30, 2025	$0.0117	Dec 31, 2025
Dec 18, 2025	$8.5742	Dec 19, 2025
Dec 30, 2024	$0.0293	Dec 31, 2024
Dec 18, 2024	$0.9958	Dec 19, 2024
Dec 28, 2023	$0.0873	Dec 29, 2023
Dec 19, 2023	$0.4663	Dec 20, 2023

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Aug 28, 2026

Data Sources Report a data error